PPARD and Insulin resistance: On the other hand PPAR-δ is believed to be as a downstream target of the β-catenin/Wnt pathway (23), which conducts several favorable effects including suppressing atherogenic inflammation, decreasing insulin resistance, improving glycemic control, elevating high-density lipoprotein, and increasing fatty acid oxidation (23-25).